Aiwu Ruth He

Presentation(s):

• O-1: Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the Phase 3 TOPAZ-1 study

  Wednesday, June 29, 2022
  17:15 – 17:27